GBT
RGEN icon

Grove Bank & Trust’s Repligen RGEN Stock Holding History

Grove Bank & Trust’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.32K Buy
39
+18
+86% +$2.21K ﹤0.01% 720
2026
Q1 		$2.47K Buy
21
+3
+17% +$419 ﹤0.01% 773
2025
Q4 		$2.95K Buy
+18
New +$2.82K ﹤0.01% 774
2025
Q2 		– Sell
-19
Closed -$2.42K – 902
2025
Q1 		$2.42K Buy
+19
New +$2.92K ﹤0.01% 762
2023
Q4 		– Sell
-15
Closed -$2.38K – 685
2023
Q3 		$2.38K Buy
+15
New +$2.45K ﹤0.01% 634

Other funds holding RGEN

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
CF
Covea Finance Paris, France $3.17B AUM 35.01% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

Grove Bank & Trust's RGEN Position: Q2 2026 in Review

Grove Bank & Trust increased its Repligen (RGEN) stake by 86% in Q2 2026, buying an estimated $2.21K and bringing the position to 39 shares worth $5.32K. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Grove Bank & Trust first reported a position in RGEN in Q3 2023 and has held it in 5 quarters since. 59 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Grove Bank & Trust held 39 shares of Repligen worth $5.32K as of Q2 2026.
  • Grove Bank & Trust bought 18 Repligen shares in Q2 2026, an estimated $2.21K.
  • Repligen made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #720 holding.
  • Grove Bank & Trust first reported a position in Repligen in Q3 2023 and has held it in 5 quarters since.
  • 59 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.